T1	Participants 26 111	patients with a complete radiographic regression of small cell bronchogenic carcinoma
T2	Participants 156 326	21 patients with small cell bronchogenic carcinoma who demonstrated a complete radiographic regression of their chest lesions after 3-4 months of combination chemotherapy
